Rapidly Progressive Alzheimer’s Disease in Two Distinct Autopsy Cohorts

Manuscript Number: 

18-0155R2

Author(s): 
Brian S. Appleby, James Leverenz, Jagan A. Pillai, Jiri Safar

Disclosures

Brian S. Appleby

  • Nothing to Disclose

James Leverenz

  • Consulting Fees:
    Consulting - Avid Radiopharmaceuticals, Axovant Pharmaceuticals, Bracco Diagnostics, GE Healthcare
    Grants
    • Agency: 
      GE Healthcare
      Dates: 
      9/1/17 to 8/30/19
    • Agency: 
      Genzyme/Sanofi
      Dates: 
      2.1.15 to 1/31/20
    • Agency: 
      Avid Radiopharmaceuticals
      Dates: 
      6/5/17 to 5/31/22

Jagan A. Pillai

  • Nothing to Disclose

Jiri Safar

  • Nothing to Disclose